Stock NVCT NUVECTIS PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Nuvectis Pharma, Inc.

Equities

NVCT

US67080T1088

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
6.33 USD +0.96% Intraday chart for Nuvectis Pharma, Inc. -10.21% -24.10%
05-07 Nuvectis Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 Nuvectis Pharma's Nxp900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Initiates Nuvectis Pharma at Buy with $21 Price Target
MT
HC Wainwright Initiates Nuvectis Pharma at Buy With $14 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NVCT Stock
  4. News Nuvectis Pharma, Inc.
  5. Analyst Reco.